Last update: Aug. 17, 2019
Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.
Derived from benzamide with properties similar to metoclopramide.
Indicated in chronic gastritis and dyspepsia.
Oral administration in 3 daily doses.
Since the last update we have not found published data on its excretion in breastmilk.
Its high plasma protein binding (Domínguez 2012) makes it unlikely to transfer into breastmilk in significant amounts.
It has very few bibliographical references, and is sold in few countries.
Until there is more published data on this drug in relation to breastfeeding, safer known alternatives may be preferable, especially during the neonatal period and in cases of prematurity.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Instituto de Salud Infantil, Grecia-Institute of Child's Health in Greece
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM